Latest filing published 13 Mar 2018 for Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.).
No signal scores available.
John London appears in our data through filings on Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) shares, published by SEDI. Over a trading history stretching from 21 September 2004 to 13 March 2018, the count stands at 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 13 March 2018 with a transaction in Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 2 days. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations